Sun Pharma sales rep claims he was fired for complaining about off-label marketing. (STAT Plus)

More reads

• With a flood of amendments, some senators seek to water down drug-pricing bill. (STAT Plus)
• Biotech IPOs are a mixed bag for hedge funds. (Institutional Investor)
• Novartis, AstraZeneca vet Jonathan Symonds steers back to a top post in Big Pharma, this time at GSK. (Endpoints)
• Sun Pharma sales rep claims he was fired for complaining about off-label marketing. (STAT Plus)